# Key Information and Facilitating Understanding in Informed Consent Guidance for Sponsors, Investigators, and Institutional Review Boards - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/key-information-and-facilitating-understanding-in-informed-consent-guidance-for-sponsors-investigators-and-institutional-review-boards/015fb9da-fe66-4838-a5f4-d2dd19dde786 > FDA guidance document: Key Information and Facilitating Understanding in Informed Consent Guidance for Sponsors, Investigators, and Institutional Review Boards. Issue date: March 01, 2024. Get complete insights and analysis. --- ## Details - Title: Key Information and Facilitating Understanding in Informed Consent Guidance for Sponsors, Investigators, and Institutional Review Boards - Communication Type: Guidance Document - Product Type: drugs - Office Name: Center for Drug Evaluation and Research - Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c - Issue Date: 2024-03-01 - Comment Close Date: 2024-04-30 - Last Changed: 2024-03-05 - Docket Number: FDA-2022-D-2997 ## Related Documents - [Investigator Responsibilities – Safety Reporting for Investigational Drugs and Devices: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/investigator-responsibilities-safety-reporting-for-investigational-drugs-and-devices-draft-guidance-for-industry/34f91048-9ac4-48e3-ac1e-4af23b426721) - [Use of Data Monitoring Committees in Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/use-of-data-monitoring-committees-in-clinical-trials/9d0ee35d-4fcc-4c44-88ac-f56c6a60187b) - [Addressing Misinformation About Medical Devices and Prescription Drugs: Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/addressing-misinformation-about-medical-devices-and-prescription-drugs-questions-and-answers/d6c8e69d-781e-4fe8-b28c-d3e357829a89)